Rocket


News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

DIOMED HOLDINGS INC (DIO) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/14/2008 8-K Quarterly results
03/11/2008 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "Letter from AMEX to Diomed Holdings, Inc.",
"DIOMED HOLDINGS REPORTS NOTICE REGARDING AMEX INTENT TO SEEK DELISTING OF ITS COMMON STOCK"
03/10/2008 8-K Triggering Events That Accelerate or Increase a Direct Financial Obligation under an Off-Balance Sheet Arrangement
02/25/2008 8-K Regulation FD Disclosure
02/21/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
02/13/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
01/22/2008 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Press Release"
01/16/2008 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Press Release"
01/14/2008 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Court Sets June Trial Date in Patent Litigation",
"Court Sets Hearing Date for Diomed Preliminary Injunction Against Total Vein Solutions"
01/04/2008 8-K Termination of a Material Definitive Agreement
12/19/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
12/04/2007 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "Letter from AMEX to Diomed Holdings, Inc.",
"DIOMED HOLDINGS REPORTS NOTICE REGARDING AMEX LISTING STANDARDS"
10/25/2007 8-K Quarterly results
Docs: "DIOMED ANNOUNCES THIRD QUARTER RESULTS Company Delivers 24% Increase in EVLT Sales ANDOVER, MA, October 25, 2007 --- Diomed Holdings, Inc. , a leading developer and marketer of minimally invasive medical technologies, including its patented EVLT® laser treatment for varicose veins, today announced results for the third quarter ended September 30, 2007. Significant accomplishments during the third quarter included:"
10/24/2007 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Diomed Responds to VNUS Patent Litigation Trial Delay and Summary Judgment Motion Ruling"
10/04/2007 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Diomed Comments on Summary Judgment Rulings in VNUS Patent Infringement Lawsuit"
10/01/2007 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Loan and Security Agreement, by and between Diomed Holdings, Inc. and Diomed, Inc., on the one hand, and Hercules Technology Growth Capital, Inc., on the other hand (Schedules Omitted)",
"Trademark Security Agreement, by and between Diomed Holdings, Inc. and Diomed, Inc., on the one hand, and Hercules Technology Growth Capital, Inc., on the other hand",
"Collateral Grant of Security Interest in Copyrights, by and between Diomed Holdings, Inc. and Diomed, Inc., on the one hand, and Hercules Technology Growth Capital, Inc., on the other hand",
"Patent Security Agreement, by and between Diomed Holdings, Inc. and Diomed, Inc., on the one hand, and Hercules Technology Growth Capital, Inc., on the other hand",
"Stock Pledge Agreement, by and between Diomed Holdings, Inc. and Diomed, Inc., on the one hand, and Hercules Technology Growth Capital, Inc., on the other hand and Hercules Technology Growth Capital, Inc., on the other hand",
"Share Charge Agreement, by and between Diomed, Inc. and Hercules Technology Growth Capital, Inc",
"Warrant Agreement, between Diomed Holdings, Inc. and Hercules Technology Growth Capital, Inc",
"Debenture Holder Agreement and Consent, between Diomed Holdings, Inc. and each holder of Variable Rate Convertible Debentures due October 2008 (Schedules Omitted)",
"Intercreditor Agreement, by and between Hercules Technology Growth Capital, Inc., on the one hand, and each holder of Amended and Restated Secured Subordinated Convertible Debentures due October 2008"
08/02/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
07/26/2007 8-K Quarterly results
Docs: "DIOMED ANNOUNCES RECORD SECOND QUARTER RESULTS"
07/03/2007 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Judge Grants Diomed Permanent Injunction in ‘777 Patent Case"
05/23/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Regulation FD Disclos...
Docs: "Vice President Finance"
05/17/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
05/16/2007 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Amendment to Distribution Agreement, entered into on May 11, 2007, between Diomed, Inc. and Luminetx Corporation"
04/26/2007 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "DIOMED ANNOUNCES FIRST QUARTER RESULTS"
03/30/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "Letter from American Stock Exchange to Diomed Holdings, Inc."
03/28/2007 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Diomed Wins Patent Infringement Case AngioDynamics and Vascular Solutions Found To Infringe EVLT ® Patent"
03/21/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
03/14/2007 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "EVLT Laser 2005 Variable Contribution Margin"
02/26/2007 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "DIOMED ANNOUNCES RECORD FOURTH QUARTER AND FULL YEAR RESULTS"
02/07/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "Change in Control Severance Agreement, between the Company and James A. Wylie, Jr",
"Change in Control Severance Agreement, between the Company and David Swank",
"Change in Control Severance Agreement, between the Company and Cary Paulette",
"Change in Control Severance Agreement, dated February 2, 2007,between the Company and John Welch",
"Change in Control Severance Agreement, between the Company and William Allan",
"Change in Control Severance Agreement, between the Company and Christopher Geberth"
12/11/2006 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Court Sets Trial Date in Diomed EVLT Patent Litigation"
11/21/2006 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Court Rules in Markman Hearing on VNUS Patents"
11/06/2006 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Court Sets Date in Diomed Patent Litigation"
10/31/2006 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "Exhibit 99-1 Diomed Names William Allan Managing Director of UK Operations"
10/26/2006 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "DIOMED ANNOUNCES THIRD QUARTER RESULTS"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy